J&J's nearly $17 billion offer to buy a heart pump maker goes right to why we own it

Johnson & Johnson's (JNJ) $16.6 billion deal to buy heart pump maker Abiomed (ABMD) will bolster its pharmaceutical and medical device business.

from Health and Science https://ift.tt/mP6Kb3F
https://ift.tt/vyJ5LbP
https://ift.tt/A16WQhO